*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| E883 - Tumor lysis syndrome - as a primary diagnosis code | E883 - Tumor lysis syndrome - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 11.98 | |
| Readmission Rate (%) | 41.21 | |
| Unplanned Readmission Rate (%) | 20.95 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 673: OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 674: OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|
| Total Hospitalizations at DRG | 434,264 | |||
| Total Hospitalizations with ICD E883 - Tumor lysis syndrome | 441 | |||
| DRG Share of Total Hospitalizations | 1.32 | |||
| % of Total ICD E883 - Tumor lysis syndrome in DRG | 46.13 | |||
| Avg LOS at DRG | 3.94 | |||
| Avg LOS with ICD E883 - Tumor lysis syndrome | 4.21 | |||
| Readmission Rate at DRG | 22.76 | |||
| Readmission Rate with ICD E883 - Tumor lysis syndrome | 37.41 | |||
| Unplanned Readmission Rate at DRG | 16.46 | |||
| Unplanned Readmission Rate with ICD E883 - Tumor lysis syndrome | 19.07 | |||
| Total Medicare payments at DRG | $2,472,138,198 | |||
| Total Medicare payments with ICD E883 - Tumor lysis syndrome | $3,346,610 | |||
| Total Medicare payment per Day at DRG | $1,444 | |||
| Total Medicare payment per Day with ICD E883 - Tumor lysis syndrome | $1,801 | |||
| Total Medicare payment per Hospitalization at DRG | $5,693 | |||
| Total Medicare payment per Hospitalization with ICD E883 - Tumor lysis syndrome | $7,589 | |||
| Total Medicare Charges at DRG | $12,478,361,060 | |||
| Total Medicare Charges with ICD E883 - Tumor lysis syndrome | $23,992,666 | |||
| Avg Charges at DRG | $28,735 | |||
| Avg Charges with ICD E883 - Tumor lysis syndrome | $54,405 | |||
| Mortality Rate at DRG | 0.91 | |||
| Mortality Rate with ICD E883 - Tumor lysis syndrome | 2.95 | |||
| SNF Discharge Rate at DRG | 22.02 | |||
| SNF Discharge Rate with ICD E883 - Tumor lysis syndrome | 7.48 | |||
| Home Discharge Rate at DRG | 46.68 | |||
| Home Discharge Rate with ICD E883 - Tumor lysis syndrome | 63.49 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 15 |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 11 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 834: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 29,081 | ||||
| Total Hospitalizations with ICD E883 - Tumor lysis syndrome | 2,508 | ||||
| DRG Share of Total Hospitalizations | 0.09 | ||||
| % of Total ICD E883 - Tumor lysis syndrome in DRG | 19.44 | ||||
| Avg LOS at DRG | 9.8 | ||||
| Avg LOS with ICD E883 - Tumor lysis syndrome | 11.83 | ||||
| Readmission Rate at DRG | 37.3 | ||||
| Readmission Rate with ICD E883 - Tumor lysis syndrome | 42.06 | ||||
| Unplanned Readmission Rate at DRG | 22.57 | ||||
| Unplanned Readmission Rate with ICD E883 - Tumor lysis syndrome | 22.52 | ||||
| Total Medicare payments at DRG | $683,745,757 | ||||
| Total Medicare payments with ICD E883 - Tumor lysis syndrome | $72,987,866 | ||||
| Total Medicare payment per Day at DRG | $2,399 | ||||
| Total Medicare payment per Day with ICD E883 - Tumor lysis syndrome | $2,460 | ||||
| Total Medicare payment per Hospitalization at DRG | $23,512 | ||||
| Total Medicare payment per Hospitalization with ICD E883 - Tumor lysis syndrome | $29,102 | ||||
| Total Medicare Charges at DRG | $3,049,100,784 | ||||
| Total Medicare Charges with ICD E883 - Tumor lysis syndrome | $389,132,874 | ||||
| Avg Charges at DRG | $104,849 | ||||
| Avg Charges with ICD E883 - Tumor lysis syndrome | $155,157 | ||||
| Mortality Rate at DRG | 13.07 | ||||
| Mortality Rate with ICD E883 - Tumor lysis syndrome | 21.85 | ||||
| SNF Discharge Rate at DRG | 16.93 | ||||
| SNF Discharge Rate with ICD E883 - Tumor lysis syndrome | 11.16 | ||||
| Home Discharge Rate at DRG | 29.4 | ||||
| Home Discharge Rate with ICD E883 - Tumor lysis syndrome | 32.3 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 823: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 837: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 434,264 | ||||
| Total Hospitalizations with ICD E883 - Tumor lysis syndrome | 721 | ||||
| DRG Share of Total Hospitalizations | 1.32 | ||||
| % of Total ICD E883 - Tumor lysis syndrome in DRG | 5.59 | ||||
| Avg LOS at DRG | 3.94 | ||||
| Avg LOS with ICD E883 - Tumor lysis syndrome | 4.74 | ||||
| Readmission Rate at DRG | 22.76 | ||||
| Readmission Rate with ICD E883 - Tumor lysis syndrome | 37.21 | ||||
| Unplanned Readmission Rate at DRG | 16.46 | ||||
| Unplanned Readmission Rate with ICD E883 - Tumor lysis syndrome | 20.78 | ||||
| Total Medicare payments at DRG | $2,472,138,198 | ||||
| Total Medicare payments with ICD E883 - Tumor lysis syndrome | $5,367,274 | ||||
| Total Medicare payment per Day at DRG | $1,444 | ||||
| Total Medicare payment per Day with ICD E883 - Tumor lysis syndrome | $1,571 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,693 | ||||
| Total Medicare payment per Hospitalization with ICD E883 - Tumor lysis syndrome | $7,444 | ||||
| Total Medicare Charges at DRG | $12,478,361,060 | ||||
| Total Medicare Charges with ICD E883 - Tumor lysis syndrome | $40,550,460 | ||||
| Avg Charges at DRG | $28,735 | ||||
| Avg Charges with ICD E883 - Tumor lysis syndrome | $56,242 | ||||
| Mortality Rate at DRG | 0.91 | ||||
| Mortality Rate with ICD E883 - Tumor lysis syndrome | 3.88 | ||||
| SNF Discharge Rate at DRG | 22.02 | ||||
| SNF Discharge Rate with ICD E883 - Tumor lysis syndrome | 7.77 | ||||
| Home Discharge Rate at DRG | 46.68 | ||||
| Home Discharge Rate with ICD E883 - Tumor lysis syndrome | 58.39 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 820: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 435: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 3,004 | ||||
| Total Hospitalizations with ICD E883 - Tumor lysis syndrome | 156 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD E883 - Tumor lysis syndrome in DRG | 1.21 | ||||
| Avg LOS at DRG | 14.98 | ||||
| Avg LOS with ICD E883 - Tumor lysis syndrome | 20.64 | ||||
| Readmission Rate at DRG | 46.04 | ||||
| Readmission Rate with ICD E883 - Tumor lysis syndrome | 42.0 | ||||
| Unplanned Readmission Rate at DRG | 16.49 | ||||
| Unplanned Readmission Rate with ICD E883 - Tumor lysis syndrome | 17.0 | ||||
| Total Medicare payments at DRG | $137,799,613 | ||||
| Total Medicare payments with ICD E883 - Tumor lysis syndrome | $9,823,187 | ||||
| Total Medicare payment per Day at DRG | $3,063 | ||||
| Total Medicare payment per Day with ICD E883 - Tumor lysis syndrome | $3,051 | ||||
| Total Medicare payment per Hospitalization at DRG | $45,872 | ||||
| Total Medicare payment per Hospitalization with ICD E883 - Tumor lysis syndrome | $62,969 | ||||
| Total Medicare Charges at DRG | $618,563,942 | ||||
| Total Medicare Charges with ICD E883 - Tumor lysis syndrome | $52,508,096 | ||||
| Avg Charges at DRG | $205,913 | ||||
| Avg Charges with ICD E883 - Tumor lysis syndrome | $336,590 | ||||
| Mortality Rate at DRG | 11.02 | ||||
| Mortality Rate with ICD E883 - Tumor lysis syndrome | 32.69 | ||||
| SNF Discharge Rate at DRG | 17.71 | ||||
| SNF Discharge Rate with ICD E883 - Tumor lysis syndrome | 13.46 | ||||
| Home Discharge Rate at DRG | 27.46 | ||||
| Home Discharge Rate with ICD E883 - Tumor lysis syndrome | 16.67 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 870: SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 673: OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 987: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 829: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 99,217 | ||||
| Total Hospitalizations with ICD E883 - Tumor lysis syndrome | 119 | ||||
| DRG Share of Total Hospitalizations | 0.3 | ||||
| % of Total ICD E883 - Tumor lysis syndrome in DRG | 0.92 | ||||
| Avg LOS at DRG | 14.88 | ||||
| Avg LOS with ICD E883 - Tumor lysis syndrome | 17.18 | ||||
| Readmission Rate at DRG | 41.65 | ||||
| Readmission Rate with ICD E883 - Tumor lysis syndrome | 41.94 | ||||
| Unplanned Readmission Rate at DRG | 18.54 | ||||
| Unplanned Readmission Rate with ICD E883 - Tumor lysis syndrome | NA | ||||
| Total Medicare payments at DRG | $4,073,197,631 | ||||
| Total Medicare payments with ICD E883 - Tumor lysis syndrome | $7,413,361 | ||||
| Total Medicare payment per Day at DRG | $2,758 | ||||
| Total Medicare payment per Day with ICD E883 - Tumor lysis syndrome | $3,625 | ||||
| Total Medicare payment per Hospitalization at DRG | $41,053 | ||||
| Total Medicare payment per Hospitalization with ICD E883 - Tumor lysis syndrome | $62,297 | ||||
| Total Medicare Charges at DRG | $20,258,140,795 | ||||
| Total Medicare Charges with ICD E883 - Tumor lysis syndrome | $41,989,539 | ||||
| Avg Charges at DRG | $204,180 | ||||
| Avg Charges with ICD E883 - Tumor lysis syndrome | $352,853 | ||||
| Mortality Rate at DRG | 35.07 | ||||
| Mortality Rate with ICD E883 - Tumor lysis syndrome | 71.43 | ||||
| SNF Discharge Rate at DRG | 25.76 | ||||
| SNF Discharge Rate with ICD E883 - Tumor lysis syndrome | NA | ||||
| Home Discharge Rate at DRG | 4.34 | ||||
| Home Discharge Rate with ICD E883 - Tumor lysis syndrome | NA |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 318 |
| BARNES JEWISH HOSPITAL | 1 BARNES-JEWISH HOSPITAL PLZ | SAINT LOUIS | MO | 63110 | 171 |
| MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 168 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. LYNN MOSCINSKI | 12902 USF MAGNOLIA DR | TAMPA | FL | 33612 | 19 |
| Dr. MELISSA LEIGH LARSON | 1725 W HARRISON ST | CHICAGO | IL | 60612 | 16 |
| Dr. TAPAN M. KADIA | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 13 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MELISSA LEIGH LARSON | 1725 W HARRISON ST | CHICAGO | IL | 60612 | 18 |
| Dr. ZAHID IQBAL | 4501 X ST | SACRAMENTO | CA | 95817 | 16 |
| Dr. TAPAN M. KADIA | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 16 |